SCHEMBL1439702

SCHEMBL1439702

C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)CCC1CCC2OC2C1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26664382 0.98 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL13043006 0.95 PTGS1 (0.34) PTGS1PTGS2
SCHEMBL26664460 0.94 PTGS1 (0.34) PTGS1PTGS2
SCHEMBL19798085 0.94 PTGS1 (0.34) PTGS1PTGS2
SCHEMBL5162214 0.92 PTGS1 (0.34) PTGS1PTGS2
SCHEMBL15131749 0.89 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL12570113 0.89 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL19622363 0.89 PTGS1 (0.36) PTGS1PTGS2
SCHEMBL1079186 0.89 PTGS1 (0.36) PTGS1PTGS2
SCHEMBL9906141 0.88 PTGS1 (0.32) PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975357-B2 Silicone modified fatty acids, method of preparation and usage thereof NATURA INOVACAO E TECNOLOGIA DE PRODUTOS LTDA. (BR) 2015-03-10 US claimed
EP-2620464-B1 Silicone modified fatty acids, method of preparation and usage thereof NATURA INOVAC O E TECNOLOGIA DE PRODUTOS LTDA (BR) 2014-12-10 EP claimed
US-8846843-B2 Silicone modified fatty acids, method of preparation and usage thereof MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2014-09-30 US claimed
EP-2473550-B1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF MOMENTIVE PERFORMANCE MAT INC (US) 2014-05-07 EP claimed
US-20130317105-A1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF NATURA INOVACAO E TECNOLOGIA DE PRODUTOS LTDA. (BR) 2013-11-28 US claimed
EP-2620464-A1 Silicone modified fatty acids, method of preparation and usage thereof Momentive Performance Materials Inc. (US) 2013-07-31 EP claimed
EP-2473550-A1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF Momentive Performance Materials Inc. (US) 2012-07-11 EP claimed
WO-2011028214-A1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2011-03-10 WO claimed
US-20100040570-A1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2010-02-18 US claimed
US-12583975-B2 UV-curable organopolysiloxane composition and use thereof DOW TORAY CO., LTD. (JP) 2026-03-24 US disclosed
US-20260022202-A1 UV-CURABLE COMPOSITION AND USE THEREOF DOW TORAY CO LTD (JP) 2026-01-22 US disclosed
US-20250368774-A1 ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF DOW TORAY CO LTD (JP) 2025-12-04 US disclosed
US-20240191078-A1 ULTRAVIOLET-RAY-CURABLE COMPOSITION AND USE THEREOF DOW TORAY CO LTD (JP) 2024-06-13 US disclosed
US-20240174889-A1 ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF DOW TORAY CO LTD (JP) 2024-05-30 US disclosed
EP-2473550-B1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF MOMENTIVE PERFORMANCE MAT INC (US) 2014-05-07 EP disclosed
EP-2473550-B1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF MOMENTIVE PERFORMANCE MAT INC (US) 2014-05-07 EP disclosed
US-20130317105-A1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF NATURA INOVACAO E TECNOLOGIA DE PRODUTOS LTDA. (BR) 2013-11-28 US disclosed
EP-2620464-A1 Silicone modified fatty acids, method of preparation and usage thereof Momentive Performance Materials Inc. (US) 2013-07-31 EP disclosed
US-20100040570-A1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2010-02-18 US disclosed
US-20100040570-A1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130317105-A1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF ASAH1, FASN, ASAH2 PTGS1 905/4885PTGS2 864/4885
US-20100040570-A1 SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF FASN, ELOVL5, SCD5 PTGS1 700/4885PTGS2 662/4885
US-20260022202-A1 UV-CURABLE COMPOSITION AND USE THEREOF IDUA, SEM1, ARSA PTGS1 2446/4885PTGS2 2894/4885
US-12583975-B2 UV-curable organopolysiloxane composition and use thereof F12, FUCA1, XPA PTGS1 2058/4885PTGS2 2735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.